期刊文献+

非小细胞肺癌组织偶合基本氨基酸裂解酶4表达与临床病理的关系 被引量:1

Expression of PACE4 in non-small cell lung cancer and analysis of its clinicopathologic characteristics
原文传递
导出
摘要 目的 检测偶合基本氨基酸裂解酶4(PACE4)在非小细胞肺癌组织中的表达情况,并分析其与临床病理特征之间的关系,探讨其在非小细胞肺癌中发生、发展及转移等的意义.方法 选取2006年至2009年广州医科大学附属第一医院172例临床确诊的非小细胞肺癌组织及15例癌旁组织病理蜡块标本,采用免疫组织化学检测PACE4的表达,分析其与非小细胞肺癌临床病理特征的关系.结果 (1)在非小细胞肺癌组织中,PACE4染色阳性111例,阳性率为64.5% (111/172).(2)PACE4阳性表达与淋巴结转移(N分期)和临床分期有关(P<0.05),与年龄、性别、肿瘤大小(T分类)、吸烟和病理类型均无关(P>0.05).结论 PACE4在非小细胞肺癌中高表达,预示着其可能参与肿瘤的发生,发展及转移. Objective To investigate the expression of paired amino acid cleaving enzyme 4 (PACE4) protein in non-small-cell lung cancer (NSCLC), analyze the correlation of its clinicopathologic characteristics, and investigate its significance in the process of occurrence, development, and metastasis of NSCLC.Methods Between January 2006 and May 2009, the First Affiliated Hospital of Guangzhou Medical College, 172 patients with NSCLC and 15 patients with non-neoplastic tissues were chosen.Immunohistochemistry was used to detect the expression of PACE4, and clinicopathologic characteristics of NSCLC were analyzed.Results (1)The positive expression rate of PACE4 protein in NSCLC was significantly higher than that in non-tumor tissues (P 〈 0.05).PACE4 expression was observed in 111 of 172 (64.5%) NSCLC.PACE4 had cytoplasmic expression.(2)Clinicopathologically, PACE4 expression was significantly associated with lymph node metastasis (N stage) (P =0.007), and clinical stage (P =0.024).Conclusions High expression of PACE4 indicates that PACE4 may be involved in the processes of occurrence,development, and metastasis of NSCLC.
出处 《中国医师杂志》 CAS 2015年第10期1474-1476,共3页 Journal of Chinese Physician
基金 基金项目:国家自然科学基金青年科学基金资助项目(81201847)
关键词 非小细胞肺/代谢/病理学 丝氨酸内肽酶类/代谢 Carcinoma,non-small-cell lung/ME/PA Serine endopeptidases/ME
  • 相关文献

参考文献10

  • 1Viale A, Ortola C, Hervieu G, et al. Cellular localization and role of prohormone convertases in the processing of pro-melanin concentrating hormone in mammals[J]. J Biol Chem,1999,274(10) :6536-6545. 被引量:1
  • 2Seidah NG,Prat A. The biology and therapeutic targeting of the prop- rotein convertases[J]. Nat Rev Drug Discov,2012,11 (5) :367-383. 被引量:1
  • 3Mbikay M, Sirois F, Yao J, et al. Comparative analysis of expres- sion of the proprotein convertases furin, PACEA, PC1 and PC2 in human lung tumours [ J ]. Br J Cancer, 1997,75 ( 10 ) : 1509-1514. 被引量:1
  • 4Fu Y, Campbell EJ, Shepherd TG, et al. Epigenetic regulation of proprotein convertase PACEd- gene expression in human ovarian cancer cells[ J]. Mol Cancer Res,2003,1 (8) :569-576. 被引量:1
  • 5DAnjou F, Routhier S, Perreanlt JP, et al. Molecular Validation of PACE4 as a Target in Prostate Cancer[ J ]. Transl Oncol, 2011, 4(3) :157-172. 被引量:1
  • 6Lapierre M, Siegfried G, Scamuffa N, et al. Opposing function of the proprotein convertases furin and PACEA on breast cancer cells malignant phenotypes: role of tissue inhibitors of metalloprotein- ase-1 [ J ]. Cancer Res ,2007,67 ( 19 ) :9030-9034. 被引量:1
  • 7Scamuffa N, Siegfried G, Bontemps Y, et al. Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells [ J ]. J Clin Invest,2008,118 ( 1 ) : 352-363. 被引量:1
  • 8Ettinger DS, Akerley W, Borghaei H, et al. Non-small cell lung cancer, version 2. 2013 [ J]. J Natl Compr Canc Netw, 2013,11 (6) :645-653 ; quiz 653. 被引量:1
  • 9Finn RS, Press MF, Dering J, et al. Estrogen receptor, progester- one receptor, human epidermal growth factor receptor 2 ( HER2 ), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paelitaxel with lapatinib or place- bo as first-line treatment in HER2-negative or unknown metastatic breast cancer[ J]. J Clin Oncol, 2009,27 (24) :3908-3915. 被引量:1
  • 10Seidah NG, Sadr MS, Chrtien M, et al. The multifaceted proprotein convertases : their unique, redundant, complementary, and opposite functions[J]. J Biol Chem,2013,288(30) :21473-21481. 被引量:1

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部